Liberum Capital Revenue and Competitors

Location

N/A

Total Funding

Finance

Industry

Estimated Revenue & Valuation

  • Liberum Capital's estimated annual revenue is currently $48.5M per year.(i)
  • Liberum Capital's estimated revenue per employee is $231,000

Employee Data

  • Liberum Capital has 210 Employees.(i)
  • Liberum Capital grew their employee count by -4% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.1M482%N/AN/A
#2
$84.8M3233%N/AN/A
#3
$5.2M31-11%N/AN/A
#4
$430.1M14639%N/AN/A
#5
$26.5M1260%N/AN/A
#6
$7.2M435%N/AN/A
#7
$7.9M479%N/AN/A
#8
$81.6M311-1%N/AN/A
#9
$1.6M130%N/AN/A
#10
$135.2M515-16%N/AN/A
Add Company

Liberum was started in September 2007 to provide a different style of broking in an industry where clients and staff were treated poorly by other institutions.Clients wanted to work with those they could trust, who knew their needs and who worked through thick and thin. They didn’t want fair-weather friends.

keywords:N/A

N/A

Total Funding

210

Number of Employees

$48.5M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Liberum Capital News

2022-04-20 - Shore Capital Reaffirms “Buy” Rating for The Restaurant ...

Liberum Capital restated a “buy” rating and issued a GBX 160 ($2.04) price objective on shares of The Restaurant Group in a report on Monday...

2022-04-17 - THG (LON:THG) Earns Buy Rating from Liberum Capital

THG (LON:THG – Get Rating)'s stock had its “buy” rating reaffirmed by equities researchers at Liberum Capital in a research report issued to...

2022-04-13 - Oxford Biomedica (LON:OXB) Given “Buy” Rating at Liberum ...

They currently have a GBX 1,380 ($17.95) target price on the biopharmaceutical company's stock. Liberum Capital's target price would suggest a...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$34.7M2106%N/A
#2
$52.4M21017%N/A
#3
$67M21023%N/A
#4
$33.5M21051%N/A
#5
$40.4M21015%N/A